(Q35772548)

10 August 2017

1 reference

title

Benefit-risk assessment of ciclosporin withdrawal in renal transplant recipients (English)

1 reference

10 August 2017

1 reference

Eric Thervet

1

1 reference

10 August 2017

Frank Martinez

series ordinal

2

1 reference

10 August 2017

Christophe Legendre

series ordinal

3

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

27

1 reference

10 August 2017

issue

7

1 reference

10 August 2017

page(s)

457-476

1 reference

Sirolimus: a comprehensive review

10 August 2017

cites work

1 reference

12 December 2020

Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy

1 reference

12 December 2020

Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation

1 reference

12 December 2020

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

1 reference

12 December 2020

Cyclosporine and tacrolimus-associated thrombotic microangiopathy

1 reference

12 December 2020

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies

1 reference

12 December 2020

The long-term course of cyclosporine-associated chronic nephropathy

1 reference

12 December 2020

Cyclosporin A withdrawal in live related renal transplantation: long-term results

1 reference

12 December 2020

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience

1 reference

12 December 2020

Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study.

1 reference

12 December 2020

Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.

1 reference

12 December 2020

Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients

1 reference

12 December 2020

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

1 reference

12 December 2020

Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period

1 reference

12 December 2020

Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: role of sodium intake

1 reference

12 December 2020

Cyclosporine-induced renal dysfunction in experimental animals and humans.

1 reference

12 December 2020

A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection

1 reference

12 December 2020

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

1 reference

12 December 2020

Cyclosporine nephrotoxicity in lung transplant recipients

1 reference

12 December 2020

A novel approach to the treatment of chronic allograft nephropathy

1 reference

12 December 2020

Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A

1 reference

12 December 2020

The side-effects of ciclosporine-A and tacrolimus

1 reference

12 December 2020

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

1 reference

12 December 2020

Elective cyclosporine withdrawal after renal transplantation. A meta-analysis

1 reference

12 December 2020

Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.

1 reference

12 December 2020

Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen

1 reference

12 December 2020

Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.

1 reference

12 December 2020

Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease

1 reference

12 December 2020

Immunosuppressants: cellular and molecular mechanisms of action

1 reference

12 December 2020

Long-term improvement in renal function after cyclosporine reduction in renal transplant recipients with histologically proven chronic cyclosporine nephropathy.

1 reference

12 December 2020

The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol

1 reference

12 December 2020

Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants

1 reference

12 December 2020

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

1 reference

12 December 2020

Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial

1 reference

12 December 2020

Cyclosporine associated lesions in native kidneys of diabetic pancreas transplant recipients

1 reference

12 December 2020

Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: relevance to toxicity and monitoring in recipients of renal allografts

1 reference

12 December 2020

The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants

1 reference

12 December 2020

Impact of cyclosporine withdrawal on living related renal transplants: a single-center experience

1 reference

12 December 2020

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

12 December 2020

Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients

1 reference

12 December 2020

Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity

1 reference

12 December 2020

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

1 reference

12 December 2020

Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles

1 reference

12 December 2020

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

12 December 2020

Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction

1 reference

12 December 2020

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

12 December 2020

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

12 December 2020

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

12 December 2020

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

12 December 2020

Do we know the site of action of cyclosporin?

1 reference

12 December 2020

Conversion from cyclosporine to azathioprine after renal transplantation: long-term effects on renal function, rejection, and allograft survival

1 reference

12 December 2020

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

1 reference

12 December 2020

The Banff 97 working classification of renal allograft pathology

1 reference

12 December 2020

Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity

1 reference

12 December 2020

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

12 December 2020

A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years

1 reference

12 December 2020

Cyclosporine nephrotoxicity in cardiac allograft patients--a seven-year follow-up

1 reference

12 December 2020

Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study

1 reference

12 December 2020

Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression

1 reference

12 December 2020

Cardiovascular toxicities of immunosuppressive agents

1 reference

12 December 2020

Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506.

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients

1 reference

12 December 2020

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

12 December 2020

Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.

1 reference

12 December 2020

Costs of immunosuppressive therapies used in renal transplantation

1 reference

12 December 2020

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

1 reference

12 December 2020

Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine

1 reference

12 December 2020

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

1 reference

12 December 2020

Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.

1 reference

12 December 2020

Immunophilin-sensitive protein phosphatase action in cell signaling pathways

1 reference

12 December 2020

Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients

1 reference

12 December 2020

Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients

1 reference

12 December 2020

Renal transplant morphology after long-term therapy with cyclosporine.

1 reference

12 December 2020

Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans

1 reference

12 December 2020

Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity: a preliminary report

1 reference

12 December 2020

A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases

1 reference

12 December 2020

Immunosuppression withdrawal in renal transplantation

1 reference

12 December 2020

Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B.

1 reference

12 December 2020

A meta-analysis of immunosuppression withdrawal trials in renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

The mechanism of action of FK-506 and cyclosporin A.

1 reference

12 December 2020

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

12 December 2020

Improved graft survival after renal transplantation in the United States, 1988 to 1996

1 reference

12 December 2020

Long-term efficacy and safety of cyclosporine in renal-transplant recipients

1 reference

12 December 2020

A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion

1 reference

12 December 2020

The effect of cyclosporine on early graft function in human renal transplantation

1 reference

12 December 2020

10.2165/00002018-200427070-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

10 August 2017

1015866376

0 references

1 reference